Enhanced mucosal and systemic immune responses to Helicobacter pylori antigens through mucosal priming followed by systemic boosting immunizations

Immunology

Volumn 110, Issue 1, 2003, Pages 86-94

  Vajdy, Michael ^a,d   Singh, Manmohan ^a   Ugozzoli, Mildred ^a   Briones, Maylene ^a   Soenawan, Elawati ^a   Cuadra, Lina ^a   Kazzaz, Jina ^a   Ruggiero, Paolo ^b   Peppoloni, Samuele ^b,c   Norelli, Francesco ^b   Del Giudice, Giuseppe ^b   O'Hagan, Derek ^a  

^a Immunology and Infectious Diseases   (United States)

^b CHIRON VACCINES   (Italy)

^c UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^d NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CAGA PROTEIN; HELICOBACTER PYLORI VACCINE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; INTERLEUKIN 4; INTERLEUKIN 8;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CHRONIC GASTRITIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; IMMUNE RESPONSE; IMMUNIZATION; MEMORY CELL; MOUSE; NONHUMAN; PEPTIC ULCER; PRIORITY JOURNAL; STOMACH ADENOCARCINOMA; STOMACH LYMPHOMA; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL VACCINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HELICOBACTER PYLORI; IMMUNITY, MUCOSAL; IMMUNIZATION; IMMUNIZATION SCHEDULE; IMMUNIZATION, SECONDARY; IMMUNOLOGIC MEMORY; INJECTIONS, INTRAMUSCULAR; MICE; MICE, INBRED BALB C; TH1 CELLS; TH2 CELLS;

EID: 0041817682     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.2003.01711.x     Document Type: Article

References (52)

1. Del Giudice G, Covacci A, Telford JL. Montecucco C, Rappuli R. The design of vaccines against Helicobacter pylori and their development. Annu Rev Immunol 2001; 19:523-63.
2. Stein M, Rappuoli R, Covacci A. Tyrosine phosphorylation of the Helicobacter pylori CagA antigen after cag-driven host cell translocation. Proc Natl Acad Sci USA 2000; 97:1263-8.
3. Satin B, Del Giudice G, Della Bianca V et al. The neutrophilactivating protein (HP-NAP) of Helicobacter pylori is a protective antigen and a major virulence factor. J Exp Med 2000; 191:1467-76.
4. Marchetti M, Arico B, Burroni D, Figura N, Rappuoli R, Ghiara P. Development of a mouse model of Helicobacterpylori infection that mimics human disease. Science 1995; 267:1655-8.
5. Marchetti M, Rossi M, Giannelli V et al. Protection against Helicobacter pylori infection in mice by intragastric vaccination with H. pylori antigens is achieved using a non-toxic mutant or E. coli heat-labile enterotoxin (LT) as adjuvant. Vaccine 1998; 16:33-7.
6. Ghiara P, Rossi M, Marchetti M et al. Therapeutic intragastric vaccination against Helicobacter pylori in mice eradicates an otherwise chronic infection and confers protection against reinfection. Infect Immun 1997; 65:4996-5002.
7. Ferrero RL, Thiberge JM, Kansau I, Wuscher N, Huerre M, Labigne A. The GroES homolog of Helicobacter pylori confers protective immunity against mucosal infection in mice. Proc Natl Acad Sci USA 1995; 92:6499-503.
8. Lee CK, Weltzin R, Thomas WD Jr et al. Oral immunization with recombinant Helicobacter pylori urease induces secretory IgA antibodies and protects mice from challenge with Helicobacter felis. J Infect Dis 1995; 172:161-72.
9. Corthesy-Theulaz IE, Hopkins S, Bachmann D et al. Mice are protected from Helicobacter pylori infection by nasal immunization with attenuated Salmonella typhimurium phoPc expressing urease A and B subunits. Infect Immun 1998; 66:581-6.
10. Weltzin R, Kleanthous H, Guirakhoo F, Monath TP, Lee CK. Novel intranasal immunization techniques for antibody induction and protection of mice against gastric Helicobacter felis infection. Vaccine 1997; 15:370-6.
11. Kleanthous H, Myers GA, Georgakopoulos KM et al. Rectal and intranasal immunizations with recombinant urease induce distinct local and serum immune responses in mice and protect against Helicobacter pylori infection. Infect Immun 1998; 66:2879-86.
12. Gottwein JM, Blanchard TG, Targoni OS et al. Protective anti-Helicobacter immunity is induced with aluminum hydroxide or complete Freund's adjuvant by systemic immunization. J Infect Dis 2001; 184:308-14.
13. Guy B, Hessler C, Fourage S, Rokbi B, Millet MJ. Comparison between targeted and untargeted systemic immunizations with adjuvanted urease to cure Helicobaeter pylori infection in mice. Vaccine 1999; 17:1130-5.
14. Guy B, Hessler C, Fourage S, Haensler J, Vialon-Lafay E, Rokbi B, Millet MJ. Systemic immunization with urease protects mice against Heticobacter pylori infection. Vaccine 1998; 16:850-6.
15. Ferrero RL, Thiberge JM, Labigne A. Local immunoglobulin G antibodies in the stomach may contribute to immunity against Helicobacter infection in mice. Gastroenterology 1997; 113:185-94.
16. Czinn SJ, Cai A, Nedrud JG. Protection of germ-free mice from infection by Helicobacter felis after active oral or passive IgA immunization. Vaccine 1993; 11:637-42.
17. Michetti M, Kelly CP, Kraehenbuhl JP, Bouzourene H, Michetti P. Gastric mucosal alpha (4) beta (7)-integrin-positive CD4 T lymphocytes and immune protection against helicobacter infection in mice. Gastroenterology 2000; 119:109-18.
18. Quiding-Jarbrink M, Ahlstedt I, Lindholm C, Johansson EL, Lonroth H. Homing commitment of lymphocytes activated in the human gastric and intestinal mucosa. Gut 2001; 49:519-25.
19. Blanchard TG, Czinn SJ, Redline RW, Sigmund N, Harriman G, Nedrud JG. Antibody-independent protective mucosal immunity to gastric helicobacter infection in mice. Cell Immunol 1999; 191:74-80.
20. Ermak TH, Giannasca PJ, Nichols R et al. Immunization of mice with urease vaccine affords protection against Helicobacter pylori infection in the absence of antibodies and is mediated by MHC class II-restricted responses. J Exp Med 1998; 188:2277-88.
21. Mohammadi M, Czinn S, Redline R, Nedrud J. Helicobacter-specific cell-mediated immune responses display a predominant Th1 phenotype and promote a delayed-type hypersensitivity response in the stomachs of mice. J Immunol 1996; 156:4729-38.
22. Mohammadi M, Nedrud J, Redline R, Lycke N, Czinn SJ. Murine CD4 T-cell response to Helicobacter infection. TH1 cells enhance gastritis and TH2 cells reduce bacterial load. Gastroenterology 1997; 113:1848-57.
23. Lindholm C, Quiding-Jarbrink M, Lonroth H, Hamlet A, Svennerholm AM. Local cytokine response in Helicobacter pylori-infected subjects. Infect Immun 1998; 66:5964-71.
24. Saldinger PF, Porta N, Launois Pet al. Immunization of BALB/c mice with Helicobacter urease B induces a T helper 2 response absent in Helicobacter infection. Gastroenterology 1998; 115:891-7.
25. Berg EL, Mullowney AT, Andrew DP, Goldberg JE, Butcher EC. Complexity and differential expression of carbohydrate epitopes associated with L-selectin recognition of high endothelial venules. Am J Pathol 1998; 152:469-77.
26. Smythies LE, Waites KB, Lindsey JR, Harris PR, Ghiara P, Smith PD. Helicobacter pylori-induced mucosal inflammation is Th1 mediated and exacerbated in IL-4, but not IFN-gamma, gene-defident mice. J Immunol 2000; 165:1022-9.
27. Gallichan WS, Rosenthal KL. Long-term immunity and protection against herpes simplex vires type 2 in the murine female genital tract after mucosal but not systemic immunization. J Infect Dis 1998; 177:1155-61.
28. Giuliani MM, Del Giudice G, Giannelli V, Dougan G, Douce G, Rappuoli R, Pizza M. Mucosal adjuvanticity and immunogenicity of LTR72, a novel mutant of Escherichia coli heat-labile enterotoxin with partial knockout of ADP-ribosyhransferase activity. J Exp Med 1998; 187:1123-32.
29. Ugozzoli M, O'Hagan DT, Ott GS. Intranasal immunization of mice with herpes simplex vires type 2 recombinant gD2: the effect of adjuvants on mucosal and serum antibody responses. Immunology 1998; 93:563-71.
30. Mantis NJ, Kozlowski PA, Mielcarz DW, Weissenhorn W, Neutra MR. Immunization of mice with recombinant gp41 in a systemic prime/mucosal boost protocol induces HIV-1-specific serum IgG and secretory IgA antibodies. Vaccine 2001; 19:3990-4001.
31. Kowalczyk DW, Wlazlo AP, Shane S, Ertl HC. Vaccine regimen for prevention of sexually transmitted infections with human papillomavirus type 16. Vaccine 2001; 19:3583-90.
32. McCluskie MJ, Weeratna RD, Payette PJ, Davis HL. Parenteral and mucosal prime-boost immunization strategies in mice with hepatitis B surface antigen and CpG DNA. FEMS Immunol Med Microbiol 2002; 32:179-85.
33. Marx PA, Compans RW, Gettie A et al. Protection against vaginal SIV transmission with microencapsulated vaccine. Science 1993; 260:1323-7.
34. Israel ZR, Gettie A, Ishizaka ST et al. Combined systemic and mucosal immunization with microsphere-encapsulated inactivated simian immunodeficiency virus elicits serum, vaginal, and tracheal antibody responses in female rhesus macaques. AIDS Res Hum Retroviruses 1999; 15:1121-36.
35. Moldoveanu Z, Vzorov AN, Huang WQ, Mestecky J, Compans RW. Induction of immune responses to SIV antigens by mucosally administered vaccines. AIDS Res Hum Retroviruses 1999; 15:1469-76.
36. Eo SK, Gierynska M, Kamar AA, Rouse BT. Prime-boost immunization with DNA vaccine, mucosal route of administration changes the rules. J Immunol 2001; 166:5473-9.
37. Kanellos TS, Byarugaba DK, Russell PH, Howard CR, Partidos CD. Naked DNA when co-administered intranasally with heat-labile enterotoxin of Escherichia coli primes effectively for systemic B- and T-cell responses to the encoded antigen. Immunol Lett 2000; 74:215-20.
38. Bruhl P, Kerschbaum A, Eibl MM, Mannhalter JW. An experimental prime-boost regimen leading to HIV type 1-specific mucosal and systemic immunity in BALB/c mice. AIDS Res Hum Retroviruses 1998; 14:401-7.
39. Lee CK, Soike K, Giannasca P, Hill J, Weltzin R, Kleanthous H, Blanchard J, Monath TP. Immunization of rhesus monkeys with a mucosal prime, parenteral boost strategy protects against infection with Helicobacter pylori. Vaccine 1999; 17:3072-82.
40. Bergmeier LA, Mitchell EA, Hall G, Cranage MP, Cook N, Dennis M, Lehner T. Antibody-secreting cells specific for simian immunodeficiency virus antigens in lymphoid and mucosal tissues of immunized macaques. Aids 1998; 12:1139-47.
41. Lehner T, Tao L, Panagiotidi C et al. Mucosal model of genital immunization in male rhesus macaques with a recombinant simian immunodeficiency virus p27 antigen. J Virol 1994; 68:1624-32.
42. Neidleman JA, Vajdy M, Ugozzoli M, Ott G, O'Hagan D. Genetically detoxified mutants of heat-labile enterotoxin from Escherichia coli are effective adjuvants for induction of cytotoxic T cell responses against HIV-1 gag-p55. Immunology 2000; 101:154-60.
43. Partidos CD, Salani BF, Pizza M, Rappuoli R. Heat-labile enterotoxin of Escherichia coli and its site-directed mutant LTK63 enhance the proliferative and cytotoxic T-cell responses to intranasally co-immunized synthetic peptides. Immunol Lett 1999; 67:209-16.
44. Ryan EJ, McNeela E, Murphy GA, Stewart H, O'Hagan D, Pizza M, Rappuoli R, Mills KH. Mutants of Escherichia coli heat-labile toxin act as effective mucosal adjuvants for nasal delivery of an acellular pertussis vaccine: differential effects of the nontoxic AB complex and enzyme activity on Th1 and Th2 cells. Infect Immun 1999; 67:6270-80.
45. Pizza M, Giuliani MM, Fontana MR et al. Mucosal vaccines. Non toxic derivatives of LT and CT as mucosal adjuvants. Vaccine 2001; 19:2534-41.
46. Pizza M, Giuliani MM, Fontana M et al. LTK63 and LTR72, two mucosal adjuvants ready for clinical trials. Int J Med Microbiol 2000; 290:455-61.
47. Beignon AS, Briand JP, Rappuoli R, Muller S, Partidos CD. The LTR72 mutant of heat-labile enterotoxin of Escherichia coli enhances the ability of peptide antigens to elicit CD4 (+) T cells and secrete gamma interferon after coapplication onto bare skin. Infect Immun 2002; 70:3012-9.
48. Vajdy M, O'Hagan DT. Microparticles for intranasal immunization. Adv Drug Deliv Rev 2001; 51:127-41.
49. Myers GA, Ermak TH, Georgakopoulos K et al. Oral immunization with recombinant Helicobacter pylori urease confers long-lasting immunity against Helicobacter felis infection. Vaccine 1999; 17:1394-403.
50. Sutton P, Danon SJ, Walker M, Thompson LJ, Wilson J, Kosaka T, Lee A. Post-immunisation gastritis and Helicobacter infection in the mouse: a long term study. Gut 2001; 49:467-73.
51. Vajdy M, Gardner J, Neidleman J, Cuadra L, Greer C, Perri S, O'Hagan D, Polo JM. Human immunodeficiency virus type 1 Gag-specific vaginal immunity and protection after local immunizations with sindbis virus-based replicon particles. J Infect Dis 2001; 184:1613-6.
52. Gallichan W, Rosenthal K. Long-lived cytotoxic T lymphocyte memory in mucosal tissues after mucosal but not systemic immunization. J Exp Med 1996; 184:1879-90.